Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of guaranteeing the children's hospice block grant for three years.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
No specific assessment has been made of the potential merits of ring-fencing the funding for children’s hospices, or of the potential merits of guaranteeing the children’s hospice funding for three years. Details of 2025/26 funding will, however, be confirmed in due course.
We recognise the vital part that voluntary sector organisations, including hospices, play in the availability and delivery of high-quality, personalised palliative and end of life care for people of all ages, and their loved ones.
As made clear in the Health and Care Act 2022, it is the statutory duty of integrated care boards (ICBs) to commission palliative and end of life care services in response to the needs of their population, including for children and young people.
NHS England currently supports palliative and end of life care for children and young people through the Children and Young People’s Hospice Grant. Last year, NHS England confirmed that it will be renewing the funding for 2024/25, once again allocating £25 million of funding for children’s hospices, using the same prevalence-based allocation approach as in 2022/23 and 2023/24. This prevalence-based approach ensures funding matches local need.
NHS England has worked closely with sector experts and sector representatives in establishing the current prevalence-based approach to deciding allocations, as well as in determining the proposed mechanism for continued funding in 2024/25.
Funding in 2024/25 will be distributed via ICBs, in line with National Health Service devolution. All ICBs in England will be formally notified of the distribution method to be used very shortly. The Department and NHS England hope to be able to provide the greater clarity that the sector is seeking on this important funding stream to children’s hospices, in the coming weeks.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of ring-fencing the block grant for children's hospices.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
No specific assessment has been made of the potential merits of ring-fencing the funding for children’s hospices, or of the potential merits of guaranteeing the children’s hospice funding for three years. Details of 2025/26 funding will, however, be confirmed in due course.
We recognise the vital part that voluntary sector organisations, including hospices, play in the availability and delivery of high-quality, personalised palliative and end of life care for people of all ages, and their loved ones.
As made clear in the Health and Care Act 2022, it is the statutory duty of integrated care boards (ICBs) to commission palliative and end of life care services in response to the needs of their population, including for children and young people.
NHS England currently supports palliative and end of life care for children and young people through the Children and Young People’s Hospice Grant. Last year, NHS England confirmed that it will be renewing the funding for 2024/25, once again allocating £25 million of funding for children’s hospices, using the same prevalence-based allocation approach as in 2022/23 and 2023/24. This prevalence-based approach ensures funding matches local need.
NHS England has worked closely with sector experts and sector representatives in establishing the current prevalence-based approach to deciding allocations, as well as in determining the proposed mechanism for continued funding in 2024/25.
Funding in 2024/25 will be distributed via ICBs, in line with National Health Service devolution. All ICBs in England will be formally notified of the distribution method to be used very shortly. The Department and NHS England hope to be able to provide the greater clarity that the sector is seeking on this important funding stream to children’s hospices, in the coming weeks.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to use (a) licensing and (b) planning powers to reduce the number of mini markets trading in illegal vapes.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is concerned about the increase in the number of illicit vapes in the United Kingdom’s market, as well as the access and availability of these vapes to children. In April of last year, we provided £3 million of funding for a new enforcement unit to tackle the illegal and underage sale of vapes, which has conducted targeted inspections in retail outlets and ports, upskilled trading standards officers, and piloted online underage test programmes.
Whilst there are no current plans to introduce a licensing scheme, we have also recently announced a further £30 million of additional funding per year to tackle illicit and underage sales of tobacco and vape products. This additional funding in England will boost agencies such as local trading standards, to enforce the new age of sale and vaping restrictions.
Alongside this package of funding, we are also taking assertive action to reduce youth vaping more generally. We recently published our response to the smoking and vaping consultation, which sets out plans to reduce the appeal and availability of vapes to children, through introducing restrictions on flavours, packaging, and point of sale display. Our response to the consultation is available at the following link:
We have also announced that we will ban the sale and supply of disposable vapes, and have set out plans to introduce a £100 fixed penalty notice for underage sales of tobacco and vaping products. The Government will introduce legislation as soon as possible.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking with Cabinet colleagues to help tackle the (a) criminal, (b) health and (c) licensing issues arising from the sale of illegal vapes.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is concerned about the increase in the number of illicit vapes in the United Kingdom’s market, as well as the access and availability of these vapes to children. In April of last year, we provided £3 million of funding for a new enforcement unit to tackle the illegal and underage sale of vapes, which has conducted targeted inspections in retail outlets and ports, upskilled trading standards officers, and piloted online underage test programmes.
Whilst there are no current plans to introduce a licensing scheme, we have also recently announced a further £30 million of additional funding per year to tackle illicit and underage sales of tobacco and vape products. This additional funding in England will boost agencies such as local trading standards, to enforce the new age of sale and vaping restrictions.
Alongside this package of funding, we are also taking assertive action to reduce youth vaping more generally. We recently published our response to the smoking and vaping consultation, which sets out plans to reduce the appeal and availability of vapes to children, through introducing restrictions on flavours, packaging, and point of sale display. Our response to the consultation is available at the following link:
We have also announced that we will ban the sale and supply of disposable vapes, and have set out plans to introduce a £100 fixed penalty notice for underage sales of tobacco and vaping products. The Government will introduce legislation as soon as possible.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of availability of follow up MRI scans for women who have undergone mastectomies to tackle lobular breast cancer.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
£2.3 billion was awarded at Spending Review 2021 to transform diagnostic services over the next three years. Most of this will help increase the number of community diagnostic centres up to 160 by March 2025, expanding and protecting elective planned diagnostic services. The remainder of the funding will increase capacity for imaging, including MRI scans, endoscopy as well as lung and mammography screening, and improve digital diagnostics.
Growth in the MRI asset base and increased use of MRI acceleration software is creating additional capacity for approximately 572,000 MRI examinations per annum within the NHS in England.
The Department and NHS England have taken steps to improve the treatment of invasive lobular breast cancer (ILBC) but are aware that more needs to be done. In September 2022, the National Cancer Audit Collaborating Centre announced funding from NHS England and the Welsh Government of £5.4 million to support delivery of six new national cancer audits. Two of these focus on breast cancer, one on primary and one on metastatic, and include ILBC.
Additionally, the National Institute for Health and Care Research (NIHR) supports breast cancer research funded by research partners in the charity and public sectors. Over the last five years, the NIHR Clinical Research Network has supported 10 ILBC-related studies.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 January 2024 to Question 10927 on Mental Health Services: Children and Young People, what the average waiting time was from referral to assessment for a child referred to the Child and Adolescent Mental Health Service in the latest period for which data is available; and how many children are on a waiting list in each local authority within the NHS North East and North Cumbria Integrated Care Board area.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The information regarding the average waiting time from referral to assessment for a child referred to the Child and Adolescent Mental Health Service, in the latest period for which data is available, as well as how many children are on waiting lists in each local authority within the North East and North Cumbria Integrated Care Board, is shown in the attached tables.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 January 2024 to Question 10925 on Liver Diseases: Darlington, how much and what proportion of the £30,000 for County Durham and Darlington NHS Foundation Trust will be spent in Darlington.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The breakdown of funding requested is not held by the Department.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what research the Government is funding on tackling lobular breast cancer.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department invests over £1 billion per year in health research through the National Institute for Health Research (NIHR), with NIHR expenditure for all cancers being £121.8 million in 2022/23.
Current NIHR research into breast cancer includes a £1.3 million project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening through mammography, such as lobular breast cancer. The NIHR also supports research on lobular breast cancer through its research infrastructure, including Biomedical Research Centres which are undertaking research on early detection and genetic aspects of breast cancer. It is difficult to attribute research infrastructure funding allocations to specific disease and therapy areas as the staff and facilities funded through the NIHR infrastructure supports research across disciplines.
Additionally, the NIHR supports breast cancer research funded by research partners in the charity and public sectors through the NIHR’s Clinical Research Network (CRN). Over the last five years the CRN has supported delivery of 10 lobular breast cancer-related studies.
Research on the underpinning science to understand the mechanisms of cancer, including lobular breast cancer, is funded through the UK Research and Innovation’s (UKRI) Medical Research Council who spend £125 million annually on cancer research. The NIHR also works closely with research funding partners including Cancer Research UK, Breast Cancer Now, Medical Research Council, and other cancer charities.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to tackle liver disease in the North East.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Northern Cancer Alliance is supporting services to enable the early detection of liver disease across the North East and North Cumbria Integrated Care System (ICS). More than 80% of patients with liver cirrhosis, a type of liver disease, have been invited to monthly ultrasound surveillance. This investment has also included £30,000 for the County Durham and Darlington NHS Foundation Trust who will be using their funds to improve systems in relation to call and recall of patients to their six-monthly checks.
Liver disease has several causes and can be associated with alcohol use or being overweight. The Government is investing significant amounts year on year in alcohol treatment through our 10-year drug strategy. In 2024/2025 the North East will receive a further £27 million, beyond funding provided by the Public Health Grant. Partners are also using a whole system approach to develop a healthy weight and treating obesity strategy for the North East and North Cumbria.
The Department is supporting people with alcohol dependency through the Drug Strategy and NHS Long Term Plan by facilitating more people in need of treatment into local authority commissioned alcohol treatment services. Additional treatment and recovery funding, made available through the Drug Strategy, can also be used to increase capacity for screening for liver fibrosis in treatment settings and to establish effective referral pathways into treatment for liver disease.
Asked by: Peter Gibson (Conservative - Darlington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the rate of liver disease in (a) Darlington constituency and b) the North East.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Office for Health Improvement and Disparities publishes liver disease profiles that compare local areas within England. Data for the prevalence of liver disease is not collected. The profiles provide liver disease mortality and hospital admissions rates for areas to assess their local level of disease. These profiles do not publish data by constituency; however, the profile does publish data for local authorities.
In the Darlington Unitary Authority, during 2021, the rate of mortality from liver disease was 26.4 (17.3 to 38.4) per 100,000 population aged under 75 years old. In 2021/22, the hospital admission rate due to liver disease was 177.8 (122.6 to 239.3) per 100,000 population across all ages.
In the North East region, during 2021, the rate of mortality from liver disease was 28.8 (26.7 to 31.0) per 100,000 population aged under 75 years old. The North East regional rate was significantly higher than the England mortality rate of 21.2 per 100,000 and was the second highest regional rate in England. In 2021/22, the hospital admission rate in the North East region due to liver disease was 190.1 (178.6 to 201.7) per 100,000 population across all ages. The North East regional rate was significantly higher than the England hospital admission rate of 150.6 per 100,000 and was the highest regional rate in England.